The
Fund is a financial instrument, not an implementing
entity.
The
Fund will make available and leverage additional financial
resources to combat HIV AIDS, tuberculosis and malaria.
The
Fund will base its work on programs that reflect national
ownership and respect country-led formulation and
implementation processes.
The
Fund will seek to operate in a balanced manner in
terms of different regions, diseases and interventions.
The
Fund will pursue an integrated and balanced approach
covering prevention, treatment, and care and support in
dealing with the three diseases.
The
Fund will evaluate proposals through independent review
processes based on the most appropriate scientific
and technical standards that take into account local realities
and priorities.
The
Fund will seek to establish a simplified, rapid, innovative
process with efficient and effective disbursement
mechanisms, minimizing transaction costs and operating
in a transparent and accountable manner based on clearly
defined responsibilities. The Fund should make use of
existing international mechanisms and health plans.
Focus
on best practices by funding interventions that work
and can be scaled up to reach people affected by HIV AIDS,
tuberculosis, and malaria.
Strengthen
and reflect high-level, sustained political involvement
and commitment in making allocations of its resources.
Support
the substantial scaling up and increased coverage of proven
and effective interventions, which strengthen systems
for working: within the health sector; across government
departments; and with communities.
Build
on, complement, and co-ordinate with existing regional
and national programs (including governments, public/private
partnerships, NGOs, and civil society initiatives) in
support of national policies, priorities and partnerships,
including Poverty Reduction Strategies and sector-wide
approaches.
Focus
on performance by linking resources to the achievement
of clear, measurable and sustainable results.
Focus
on the creation, development and expansion of government/private/NGO
partnerships.
Strengthen
the participation of communities and people, particularly
those infected and directly affected by the three diseases,
in the development of proposals.
Are
consistent with international law and agreements,
respect intellectual property rights, such as Trade-Related
Aspects of Intellectual Property Rights (TRIPS), and encourage
efforts to make quality drugs and products available at
the lowest possible prices for those in need.
Give
due priority to the most affected countries and communities,
and to those countries most at risk.
Aim
to eliminate stigmatisation of and discrimination
against those infected and affected by HIV AIDS, especially
for women, children and vulnerable groups.
